Targeted liver chemo shows promise as potent alternative for Tough-to-Treat bile duct cancer
NCT ID NCT07466238
Summary
This study is testing a two-part treatment for advanced bile duct cancer, which is often found too late for surgery. It combines a strong, targeted chemotherapy infusion directly into the liver with standard cancer drugs given through the bloodstream. The goal is to see if this approach can shrink tumors more effectively and help patients live longer than current standard treatments alone.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BILIARY TRACT CANCER (BTC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking University Cancer Hospital
Beijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.